Format

Send to

Choose Destination
See comment in PubMed Commons below
Seizure. 2009 Sep;18(7):492-7. doi: 10.1016/j.seizure.2009.04.009. Epub 2009 May 21.

Variable neurologic phenotype in a GEFS+ family with a novel mutation in SCN1A.

Author information

  • 1Clinical Epidemiology Unit, Faculty of Medicine, Memorial University, St. John's, NL, Canada. kmahoney@mun.ca

Abstract

PURPOSE:

To describe the spectrum of clinical disease in a mutliplex family with an autosomal dominant form of generalized epilepsy with febrile seizures plus (GEFS+) and determine its genetic etiology.

METHODS:

Medical and family history was obtained on 11 clinically affected individuals and their relatives across three generations through medical chart review and home visits. A candidate gene approach including haplotype analysis and direct sequencing was used.

RESULTS:

An epilepsy-associated haplotype was identified on 2q24. Direct sequencing of the entire SCN1A gene identified seven sequence variants. However, only one of these, c.1162 T>C, was not found in population controls. This transition in exon 8 of SCN1A predicts a substitution (Y388H) of a highly conserved tyrosine residue in the loop between transmembrane segments S5 and S6 of the sodium channel protein (Na(v)1.1). Clinical features in mutation carriers of this novel missense mutation were highly variable, ranging from febrile seizures to severe refractory epilepsy.

CONCLUSION:

A novel missense mutation in the pore-forming region of the sodium channel gene SCN1A causes GEFS+ with a variable phenotype that includes mood and anxiety disorders, as well as ataxia, expanding the GEFS+ spectrum to include neuropsychiatric disease.

PMID:
19464195
DOI:
10.1016/j.seizure.2009.04.009
[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center